Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.
about
Update in lung cancer 2007CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trialsNeoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancerSystemic and targeted therapies for early-stage lung cancerPreoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant dataPreoperative functional workup for patients with advanced lung cancerThe long-term prognosis of induction chemotherapy followed by surgery for N2 non-small cell lung cancer: A retrospective case series study.Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L)Adjuvant or neoadjuvant chemotherapy for NSCLC.Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trialTrimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis.alpha5beta1-integrin expression is essential for tumor progression in experimental lung cancer.Involvement of TRPC channels in lung cancer cell differentiation and the correlation analysis in human non-small cell lung cancerAnticancer actions of PPARĪ³ ligands: Current state and future perspectives in human lung cancerHealth-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.How close are we to customizing chemotherapy in early non-small cell lung cancer?Opportunistic illnesses in Brazilian children with AIDS: results from two national cohort studies, 1983-2007.Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study)Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis.Evolution of induction chemotherapy for non-small cell lung cancer over the last 30 years: A surgical appraisalLung cancer: Biology and treatment options.Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint.A retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer.Activated PPARgamma Targets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells.Minimally invasive (robotic assisted thoracic surgery and video-assisted thoracic surgery) lobectomy for the treatment of locally advanced non-small cell lung cancerWhat is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer.Feasibility of complete video-assisted thoracoscopic surgery following neoadjuvant therapy for locally advanced non-small cell lung cancer.Perioperative outcomes and lymph node assessment after induction therapy in patients with clinical N1 or N2 non-small cell lung cancerLung cancer surgery: an up to date.Five-Year Survival Among Stage IIIA Lung Cancer Patients Receiving Two Different Treatment ModalitiesControversies in the management of stage IIIA non-small-cell lung cancer.Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer.Vinorelbine for non-small cell lung cancer.Treatment in resectable, locally advanced NSCLC: which is the best approach?Neo-adjuvant chemotherapy in early stage non-small cell lung cancer.Controversies in the management of stage III non-small-cell lung cancer.Recurrence after surgery in patients with NSCLC.Tubulin inhibitors in non-small cell lung cancer: looking back and forward.Optimum treatment for mediastinal lymph node positive (N2) resectable non-small cell lung cancer: What is the role for surgery?
P2860
Q22241904-C0DE948B-9CF7-490D-980A-6F22DF18C4BFQ24614627-03E70FF2-3DA6-42DC-BD1C-E08E5AF04D8AQ26863742-8484C2FB-A484-4360-AF14-F4EF30E7F417Q26865490-4E6DA95A-45B6-42F3-A4EE-CFF67CD5650AQ27010262-1AEF519E-0B00-4C93-8FE9-46A9660CA603Q28076183-8585C37C-F584-4E64-8058-A2B5A2137DE5Q33613087-4154BE25-3EC1-4472-9823-2D66AFC524F8Q33623604-08A3A4B1-784E-438D-B58C-CAAAED546281Q33658228-ECEEF19A-627B-45B9-BD14-692D45549C49Q33813436-26601974-4A05-4F40-B76E-7D1019360C6CQ34062649-CB4BA840-3B68-4308-B651-416BDE0B7084Q34357105-E596A1A0-B4BC-4FF8-80CA-06FE6E03F224Q34807837-BB240DCB-7CCB-46B8-AF3C-D4155175346CQ34878637-7E92E126-2D37-45AB-A940-E49C27B6653DQ35111780-99D01E53-6B06-489C-9BE7-AC6F1152BA08Q35146944-670C9372-CDBF-4D53-93E0-92E6AA96AFBFQ35147409-3BFA8A97-B9B7-459E-B80D-8F7FED3539DBQ35644940-748082A6-D46C-4EFA-9721-2D3F620FFDCFQ36194277-0BBE9B89-0B20-4133-8E1E-606639783AD1Q36247875-C0E61825-9DC1-46DE-BAF3-E4761CAB0DB3Q36328370-6666EBB7-D55A-4661-B292-0EFE19914E0AQ36525431-CCBD3369-FFEE-4A9B-AE53-83FC16742BD7Q36752521-B661762E-AC67-4A9A-801D-117D00A929C4Q36836697-83D6F20D-B56F-4EBE-9AA0-17CF86837506Q36870165-41F0855D-3AA1-4BD4-8FC0-4E59A78B04B3Q37085999-34E17E2F-38A2-4971-91F6-FC580DA77DF8Q37090628-BAB10205-390F-49B5-BD3A-3DDCBCCEA984Q37167056-D4611AF2-25DD-4119-A13A-CFB34C93F5F4Q37208623-8107B32E-5713-4E86-8FFC-5BC184A52529Q37217756-2ABAF751-2440-4251-A583-81D728C94FA0Q37245399-EF08C3DC-CC11-449C-9DB6-8A14BBD7B4DAQ37338248-954058A4-A6D2-4D7D-BCE8-5F323B968388Q37478345-5DA2E313-7C97-436C-8B92-DFD241BC2846Q37720767-0D26654B-0690-422B-9947-22052EBE20B4Q37755004-30C6593C-59FA-4308-B342-2AE32B3656ABQ38150350-EFA86DA5-2AEE-46E7-8EE1-C554D14D98DFQ38176433-DC529617-16DC-4AD6-AD30-781668F5F509Q38390164-3EAA8CD7-4724-4BA3-B226-A09DBF8B7118Q38742506-730D5DB3-D22D-41BD-A832-5E9B59F212B3Q38818969-6D8A1D50-CAEE-4483-961E-10741CDFCDFA
P2860
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.
description
2007 nĆ® lÅ«n-bĆ»n
@nan
2007幓ć®č«ę
@ja
2007幓č«ę
@yue
2007幓č«ę
@zh-hant
2007幓č«ę
@zh-hk
2007幓č«ę
@zh-mo
2007幓č«ę
@zh-tw
2007幓č®ŗę
@wuu
2007幓č®ŗę
@zh
2007幓č®ŗę
@zh-cn
name
Preoperative chemotherapy in p ...... d update of systematic review.
@en
type
label
Preoperative chemotherapy in p ...... d update of systematic review.
@en
prefLabel
Preoperative chemotherapy in p ...... d update of systematic review.
@en
P2093
P1433
P1476
Preoperative chemotherapy in p ...... d update of systematic review.
@en
P2093
Cheryl Pugh
Christian Manegold
David Gilligan
Franz Schramel
Harry Groen
Jan van Meerbeeck
Mahesh Parmar
Marianne Nicolson
P304
P356
10.1016/S0140-6736(07)60714-4
P407
P577
2007-06-01T00:00:00Z